H-CYTE, Inc. (HCYT) 是一家上市公司 属于 医疗保健 板块，经营于 生物科技 行业. 公司总部位于 Tampa, FL, 美国. 现任CEO为 Michael W. Yurkowsky.
HCYT 拥有 IPO日期为 2014-12-19, 2 名全职员工, 在 Other OTC, 市值为 $624.98K.
H-CYTE, Inc., a biopharmaceutical company, develops and delivers various treatments for patients with chronic respiratory and pulmonary disorders in the United States. The company develops and implements treatment options in autologous cellular therapy to treat chronic lung disorders. It has a product supply agreement with Rion, LLC to develop and distribute a biologic for chronic obstructive pulmonary disease. The company is headquartered in Tampa, Florida.
